See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Elo Eriste

https://etis.ee/CV/Elo_Eriste/est
19.06.1972
7330402
eristeelo@gmail.com

Teenistuskäik

Töökohad ja ametid
2014–...   
Tervisetehnoloogiate Arenduskeskus AS (endine Reproduktiivmeditsiini TAK AS) , Teadur (1,00)
01.01.2014–28.02.2014   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, molekulaarse biomeditsiini vanemteadur (0,50)
01.09.2009–31.12.2013   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, molekulaarse biomeditsiini vanemteadur (1,00)
01.03.2009–31.08.2009   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, teadur (1,00)
01.01.2008–28.02.2009   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, biokeemia erakorraline vanemteadur (1,00)
01.03.2006–31.12.2007   
Tartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut, biokeemia erakorraline vanemteadur (1,00)
01.01.1998–31.12.2000   
Külalisteadur, Karolinska Instituut, Rootsi
 
 
Haridustee
2004–2005   
Järeldoktorantuur Karolinska Instituut, Stockholm, Rootsi
2001–2004   
PhD Meditsiiniline biokeemia, Karolinska Instituut, Rootsi
1995–1998   
MSc Bioorgaanilises keemias, TÜ Füüsika- ja keemiateaduskond, Tartu Ülikool
1990–1995   
BSc keemias, TÜ Füüsika- ja keemiateaduskond, Tartu Ülikool
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
1998−...   
Eesti Teadusliku seltsi liige Rootsis, Stockholm
 
 
Lisainfo
15. rahvusvaheline Geenifoorum, 18-19. juuni, 2015 Tartu, Eesti "Genoomika-lõpuks ometi personaalne"
Eesti Inimesegeneetika Ühingu aastakonverents, 22-23. oktoober, 2015, Viljandi, Eesti
Eesti Inimesegeneetika Ühingu aastakonverents 23.-24. oktoober 2014, Otepää Gümnaasium, Eesti
Peptide Vectors and Delivery of Therapeutics. 19-21 May 2011 Tallinn, Estonia


Rahvusvaheline Geenifoorum 2010, "Funktsionaalne ja komplekshaiguste geneetika", 18-19, juuni, 2010, Tartu, Eesti
31EPS CPP Satellite meeting in Copenhagen. "Cell Penetrating Peptides". University of Copenhagen, Health Science Faculty, The Panum Institute, 10.09.2010 - 11. 09.2010.
Rahvusvaheline Geenifoormum, "Funktsionaalne genoomika", 12-14. juuni, 2008, Tartu, Eesti.
The 1st International Symposium on Short-chain Dehydrogenases/reductases in Cancer and other Diseases, 2002, Buffalo, USA.
The 49th ASMS Conference on Mass Spectrometry and Allied Topics in Chicago, USA. Abstract"Determination of metal-protein complexes and posttransaltional modifications by LC-(ESI-TOF)-MS. 2001, Chicago, USA.

Kvalifikatsioon

Teaduskraadid
Elo Eriste, doktorikraad, 2004, (juh) Rannar Sillard; Peep Palumaa, Purification, structure and function of bioactive peptides, Karolinska Institute.
Elo Eriste, magistrikraad, 1998, (juh) Aleksandr Žarkovski, Ketamiini isomeeride neuroprotektiivne toime, Tartu Ülikool, Füüsika-keemiateaduskond, Keemilise füüsika instituut.
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.1. Biokeemia; TÄPSUSTUS: Cell-penetrating peptides, Peptiidie sünteesimine
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.12. Bio- ja keskkonnateadustega seotud uuringud, näiteks biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika, majandus- ja tehnoloogiauuringud; CERCS KLASSIFIKAATOR: T490 Biotehnoloogia ; TÄPSUSTUS: Tissue-specific peptide-based drug delivery vectors with the aim of developing novel anti-cancer agents
ETIS KLASSIFIKAATOR: 1. Bio- ja keskkonnateadused; 1.12. Bio- ja keskkonnateadustega seotud uuringud, näiteks biotehnoloogia, molekulaarbioloogia, rakubioloogia, biofüüsika, majandus- ja tehnoloogiauuringud; CERCS KLASSIFIKAATOR: T490 Biotehnoloogia ; TÄPSUSTUS: Naiste viljatuse uuringud seoses endometrioosiga
 
 
Lisainfo
Bioaaktiivsete molekulide puhastamine kromatograafiliste meetodite abil.
FSH hormoonide puhastamine piimast ja dekteerimine kromatograafiliste meetoditega ja western blotiga

Jooksvad projektid

Lõppenud projektid

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.1.
2017
Sillaste, Gerly; Kaplinski, Lauris; Meier, Riho; Jaakma, Ülle; Eriste, Elo; Salumets, Andres (2017). A novel hypothesis for histone-to-protamine transition in Bos taurus spermatozoa. Reproduction, 153 (3), 241−251. DOI: 10.1530/REP-16-0441.
3.1.
2015
Pärn, K.; Eriste, E.; Langel, Ü. (2015). The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. Methods in molecular biology, 1324, 223−245. DOI: 10.1007/978-1-4939-2806-4_15.
1.1.
2014
Copolovici, D; Langel, K; Eriste, E; Langel, Ü (2014). Cell-Penetrating Peptides: Design, Synthesis, and Applications. ACS Nano, 8 (3), 1972−1994.10.1021/nn4057269.
1.1.
2013
Villo, Piret; Toom, Lauri; Eriste, Elo; Vares, Lauri (2013). Synthesis of Linear Aza and Thio Analogues of Acetogenins and Evaluation of Their Cytotoxicity. European Journal of Organic Chemistry, 2013 (30), 6886−6899.10.1002/ejoc.201300767.
1.1.
2013
Eriste, Elo; Kurrikoff, Kaido; Suhorutšenko, Julia; Oskolkov, Nikita; Copolovici, Dana Maria; Jones, Sarah; Howl, John; Laakkonen, Pirjo; Langel, Ülo (2013). Peptide-based glioma-targeted drug delivery vector gHoPe2. Bioconjugate Chemistry, 24 (3), 305−313. DOI: 10.1021/bc300370w.
1.1.
2012
Suhorutsenko, J.; Eriste, E.; Copolovici, D. M.; Langel, Ü. (2012). Human Protein 53-Derived Cell-Penetrating Peptides. International Journal of Peptide Research and Therapeutics, 18 (4), 291−297.10.1007/s10989-012-9302-3.
1.1.
2011
Suhorutšenko, J.; Oskolkov, N.; Arukuusk, P.; Kurrikoff, K.; Eriste, E.; Copolovici, D.-M.; Langel, Ü. (2011). Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and Immunogenicity In Vitro and In Vivo. Bioconjugate Chemistry, 22 (11), 2255−2262. DOI: 10.1021/bc200293d.
1.1.
2010
Lehto, Taavi; Abes, Rachida; Oskolkov, Nikita; Suhorutsenko, Julia; Copolovici, Dana-Maria; Mager, Imre; Viola, Joana R.; Simonson, Oscar E.; Ezzat, Kariem; Guterstam, Peter; Eriste, Elo; Smith, C. I. Edvard; Lebleu, Bernard; El Andaloussi, Samir; Langel, Ulo (2010).

Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy

. Journal of Controlled Release, 141 (1), 42−51. DOI: 10.1016/j.jconrel.2009.08.028.
5.1.
2010
Suhorutsenko, J.; Copolovici, D. M.; Eriste, E.; Oskolkov, N.; Arukuusk, P.; Langel, Ü. (2010). New cell-penetrating peptides induce no inflammatory response in antigen-presenting cell lines. Scandinavian Journal of Immunology, 71, 508−509.
1.1.
2009
Dang, D.T.; Eriste, E.; Liepinsh, E.; Trinh, T.T.; Erlandsson Harris, H.; Sillard, R.; Larsson, P (2009). A novel anti-inflammatory compound, artonkin-4'-O-glucoside, from the leaves of Artocarpus tonkinensis suppresses experimentally induced arthritis. Scandinavian Journal of Immunology, 69 (2), 110-−118. DOI: 10.1111/j.1365-3083.2008.02205.x.
3.1.
2009
Hansen, M.; Eriste, E. Langel Ü. (2009). The Internalization mechanisms and Bioactivity of the Cell-Penetrating Peptides. In: Gröner, B. (Ed.). Peptides as Drugs: Discovery and Development, (125−143).. John Wiley & Sons Ltd.
1.1.
2005
Chen, J.; Kuei, C.; Sutton, S.W.; Bonaventure, P.; Nepomuceno, D.; Eriste, E.; Sillard, R.;Lovenberg, T.W.; Liu, C. (2005). Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species. Journal of Pharmacology and Experimental Therapeutics, 312 (1), 83−95.
1.1.
2005
Liu, C.; Kuei, C.; Sutton, S.; Chen, J.; Bonaventure, P.; Wu, J.; Nepomuceno, D.; Kamme, F.; Tran, D.T.; Zhu, J.; Wilkinson, T.; Bathgate, R.; Eriste, E.; Sillard, R.; Lovenberg, T.W. (2005). INSL5 is a high affinity specific agonist for GPCR142 (GPR 100). Journal of Biological Chemistry, 280 (1), 292−300.
1.1.
2005
Eriste, E.; Norberg, A.; Nepomuceno, D.; Kuei, C.; Kamme, F.; Tran, D.T.; Strumpat, K.; Jornvall, H.; Liu, C.; Lovenberg, T.W.; Sillard, R. (2005). A novel form of neurotensin post-translationally modified by arginylation. Journal of Biological Chemistry, 280 (42), 35089−35097.
1.1.
2003
Liu, C.; Eriste, E.; Sutton, S.; Chen, J.; Roland, B.; Kuei, C.; Farmer, N.; Jornvall, H.; Sillard, R.; Lovenberg, T.W. (2003). Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. Journal of Biological Chemistry, 278 (50), 50754−50764.
1.1.
2003
Palumaa, P.; Eriste, E.; Kruusel, K.; Kangur, L.; Jornvall, H.; Sillard, R (2003). Metal binding to brain-specific metallotifhonein-3 studied by electrospray ionization mass spectrometry. Cellular and Molecular Biology, 49 (5), 763−768.
1.1.
2003
Eriste, E.; Kruusel, K.; Palumaa, P.; Jornvall, H.; Sillard, R (2003). Purification of recombinant human apometallothionein-3 and reconstitution with zinc. Protein Expression and Purification, 31 (1), 161−165.
1.1.
2002
Palumaa, P.; Njunkova, O.; Pokras, L.; Eriste, E.; Sillard, R. (2002). Evidence for non-isostructural replacement of Zn<2+> with Cd<2+> in the beta-domain of brain-specific metallothionein-3. FEBS Letters, 527, 76−80.
1.1.
2002
Palumaa, P.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Sillard, R. (2002). Brain-specific metallothionein-3 has higher metal-binding capacity than ubiquitous metallothioneins and binds metals noncooperatively. Biochemistry, 41 (19), 6158−6163.
5.2.
2002
Palumaa, P.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Sillard, R. (2002). ESI TOF MS in protein structure analysis. MBB Meeting. Abstracts. Buffalo,.
5.2.
2002
"Palumaa, Peep;Eriste, Elo;Njunkova, Olga;Pokras, Lesja;Jörnvall, H.;Sillard, Rannar" (2002). Comparison of confirmations of zinc- and cadmium-substituted metallothionein-3 by ESI MS. The 50th ASMS Conference on Mass Spectrometry and Allied Topics. Orlando, puudub−puudub.
1.1.
2001
Chen, Z.; Eriste, E.; Jonsson, A. P.; Norberg, A.; Nepomuceno, D.; Lovenberg, T.W.; Bergman, T.; Efendic, S.; Jormvall, H.; Sillard, R. (2001). Ser(13)-phosphorylated PYY from porcine intestine with a potent biological activity. FEBS Letters, 492, 119−122.
1.1.
2001
Bonetto, V.; Eriste, E; Jonsson, A.P.; Efendic, S.; Jornvall, H.; Sillard, R. (2001). Isolation of peptides from porcine intestinal tissue that induce extracellular acidification in CHO cells : identification of the active peptide as IGF-I and characterization of a fragment of calponin H1 processed at a dibasic site. Archives of Biochemistry and Biophysics, 358 (2), 276−282.
5.2.
2001
Sillard, R.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Wadensten, H.; Renlund, S.; Palumaa, P. (2001). Determination of metal-protein complexes and posttranslational modifications by LC-(ESI-TOF)-MS. Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics : Chicago, Illinois, May 27-31, 2001. 11−12.
1.1.
1999
Eriste, E.; Norberg, A.; Bonetto, V.; Nepomuceno, D.; Lowenberg, T.W., Sillard, R.; Jornvall, H. (1999). A C-terminally elongated form of PHI from porcine intestine. Cellular and Molecular Life Sciences, 56, 709−713.
1.1.
1999
Bonetto, V.; Eriste, E.; Metsis, M.; Sillard, R. (1999). Extracellular acidification: A novel detection system for ligand/receptor interactions. Demonstration with bioactive peptides and CHO or pancreatic beta cells, but of possible interest for tracing putative receptors in ethanol metabolism. Advances in Experimental Medicine and Biology, 463, 351−358.
1.1.
1998
Bonetto, V.; Eriste, E.; Sillard, R. (1998). Combination of fast chromatographic separations, biosensor-based functional assays, and mass spectrometry for characterization of complex peptide mixtures. Journal of Protein Chemistry, 17 (6), 555−556.
1.1.
1998
Kalda, A.; Eriste, E.; Vassiljev, V.; Zharkovsky, A. (1998). Medium transitory oxygen-glucose deprivation induced both apoptosis and necrosis in cerebellar granule cells. Neuroscience Letters, 240 (1), 21−24.
6.7.
1998
Eriste, Elo (1998). Ketamiini isomeeride neuroprotektiivse toime uurimine kahjustatud tserebellaarsete granulaarsete rakkude primaarkultuuris. (Magistritöö, Tartu Ülikool, Füüsika-keemiateaduskond). Tartu: Tartu Ülikool.
6.7.
1998
Eriste, E. (1998). Ketamiini isomeeride neuroprotektiivse toime uurimine kahjustatud tserebellaarsete granulaarsete rakkude primaarkultuuris. (Magistritöö). Tartu,: Tartu Ülikool, Orgaanilise ja bioorgaanilise keemia instituut.

Tööstusomand

20.11.2020

Elo Eriste

https://etis.ee/CV/Elo_Eriste/eng
19.06.1972
7330402
eristeelo@gmail.com

Career

Institutions and positions
2014–...   
Competence Centre on Health Technologies, Researcher (1,00)
01.01.2014–28.02.2014   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Senior Research Fellow in Molecular Biomedicine (0,50)
01.09.2009–31.12.2013   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Senior Research Fellow in Molecular Biomedicine (1,00)
01.03.2009–31.08.2009   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Research Fellow (1,00)
01.01.2008–28.02.2009   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Senior Research Fellow extraordinarius (1,00)
01.03.2006–31.12.2007   
University of Tartu, Faculty of Science and Technology (old), Institute of Technology, University of Tartu, Senior Research Fellow extraordinarius (1,00)
01.01.1998–31.12.2000   
Guest Researcher, Karolinska Institute
 
 
Education
2004–2005   
Post-doc Karolinska Institute, Sweden
2001–2004   
PhD In Medical Biochemistry, Karolinska Institute, Sweden
1995–1998   
MSc in Bioorganic Chemistry, Faculty of Physics and Chemistry, University of Tartu
1990–1995   
BSc Chemistry, Faculty of Physics and Chemistry, University of Tartu
 
 
R&D related managerial and administrative work
1998−...   
Estonian Scientific Organisation in Sweden, Stockholm
 
 
Additional information
The 15th Annual International Gene Forum, June 18-19, 2015 Tartu, Estonia "Genomics - It`s getting personal".
The Estonian Society of Human Genetics, 22-23 October, 2015, Viljandi, Estonia
The Estonian Society of Human Genetics, 23.-24, October, 2014, Otepää Gymnasium, Estonia
Peptide Vectors and Delivery of Therapeutics. 19-21 May 2011 Tallinn, Estonia


The 10th Annual International Gene Forum 2010, "Functional and Complex Genetics", June 18-19, 2010, Tartu, Estonia
31EPS CPP Satellite meeting in Copenhagen. "Cell Penetrating Peptides". University of Copenhagen, Health Science Faculty, The Panum Institute, 10.09.2010 - 11. 09.2010.
8th Annual International Gene Forum, "Functional Genomics", 12-14, June, 2008, Tartu, Estonia.
The 1st International Symposium on Short-chain Dehydrogenases/reductases in Cancer and other Diseases, 2002, Buffalo, USA.
The 49th ASMS Conference on Mass Spectrometry and Allied Topics in Chicago, USA. Abstract"Determination of metal-protein complexes and posttransaltional modifications by LC-(ESI-TOF)-MS. 2001, Chicago, USA.

Qualifications

Academic degrees
Elo Eriste, Doctor's Degree, 2004, (sup) Rannar Sillard; Peep Palumaa, Purification, structure and function of bioactive peptides, Karolinska Institutet, Stockholm, Sweden.
Elo Eriste, Master's Degree, 1998, (sup) Aleksandr Žarkovski, Ketamiini isomeeride neuroprotektiivne toime (Neuroprotective effects of the isomers of ketamine), University of Tartu, Faculty of Physics and Chemistry, Institute of Chemical Physics.
 
 
Fields of research
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.1. Biochemistry; SPECIFICATION: ,
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.12. Biotechnology, Molecular Biology, Cell Biology, Biophysics and Economic and Technological Research relating to Bio- and Environmental Sciences; CERCS CLASSIFICATION: T490 Biotechnology
ETIS CLASSIFICATION: 1. Biosciences and Environment; 1.12. Biotechnology, Molecular Biology, Cell Biology, Biophysics and Economic and Technological Research relating to Bio- and Environmental Sciences; CERCS CLASSIFICATION: T490 Biotechnology ; SPECIFICATION: Female infertility, endometriosis
 
 
Additional information
Purification of bioactive molecules by chromatograpic methods.
Purification and detection of FSH hormones from milk by chromatographic methods and western blot.

Projects in progress

Completed projects

Publications

Category
Year
Publication
 
1.1.
2017
Sillaste, Gerly; Kaplinski, Lauris; Meier, Riho; Jaakma, Ülle; Eriste, Elo; Salumets, Andres (2017). A novel hypothesis for histone-to-protamine transition in Bos taurus spermatozoa. Reproduction, 153 (3), 241−251. DOI: 10.1530/REP-16-0441.
3.1.
2015
Pärn, K.; Eriste, E.; Langel, Ü. (2015). The Antimicrobial and Antiviral Applications of Cell-Penetrating Peptides. Methods in molecular biology, 1324, 223−245. DOI: 10.1007/978-1-4939-2806-4_15.
1.1.
2014
Copolovici, D; Langel, K; Eriste, E; Langel, Ü (2014). Cell-Penetrating Peptides: Design, Synthesis, and Applications. ACS Nano, 8 (3), 1972−1994.10.1021/nn4057269.
1.1.
2013
Villo, Piret; Toom, Lauri; Eriste, Elo; Vares, Lauri (2013). Synthesis of Linear Aza and Thio Analogues of Acetogenins and Evaluation of Their Cytotoxicity. European Journal of Organic Chemistry, 2013 (30), 6886−6899.10.1002/ejoc.201300767.
1.1.
2013
Eriste, Elo; Kurrikoff, Kaido; Suhorutšenko, Julia; Oskolkov, Nikita; Copolovici, Dana Maria; Jones, Sarah; Howl, John; Laakkonen, Pirjo; Langel, Ülo (2013). Peptide-based glioma-targeted drug delivery vector gHoPe2. Bioconjugate Chemistry, 24 (3), 305−313. DOI: 10.1021/bc300370w.
1.1.
2012
Suhorutsenko, J.; Eriste, E.; Copolovici, D. M.; Langel, Ü. (2012). Human Protein 53-Derived Cell-Penetrating Peptides. International Journal of Peptide Research and Therapeutics, 18 (4), 291−297.10.1007/s10989-012-9302-3.
1.1.
2011
Suhorutšenko, J.; Oskolkov, N.; Arukuusk, P.; Kurrikoff, K.; Eriste, E.; Copolovici, D.-M.; Langel, Ü. (2011). Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and Immunogenicity In Vitro and In Vivo. Bioconjugate Chemistry, 22 (11), 2255−2262. DOI: 10.1021/bc200293d.
1.1.
2010
Lehto, Taavi; Abes, Rachida; Oskolkov, Nikita; Suhorutsenko, Julia; Copolovici, Dana-Maria; Mager, Imre; Viola, Joana R.; Simonson, Oscar E.; Ezzat, Kariem; Guterstam, Peter; Eriste, Elo; Smith, C. I. Edvard; Lebleu, Bernard; El Andaloussi, Samir; Langel, Ulo (2010).

Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy

. Journal of Controlled Release, 141 (1), 42−51. DOI: 10.1016/j.jconrel.2009.08.028.
5.1.
2010
Suhorutsenko, J.; Copolovici, D. M.; Eriste, E.; Oskolkov, N.; Arukuusk, P.; Langel, Ü. (2010). New cell-penetrating peptides induce no inflammatory response in antigen-presenting cell lines. Scandinavian Journal of Immunology, 71, 508−509.
1.1.
2009
Dang, D.T.; Eriste, E.; Liepinsh, E.; Trinh, T.T.; Erlandsson Harris, H.; Sillard, R.; Larsson, P (2009). A novel anti-inflammatory compound, artonkin-4'-O-glucoside, from the leaves of Artocarpus tonkinensis suppresses experimentally induced arthritis. Scandinavian Journal of Immunology, 69 (2), 110-−118. DOI: 10.1111/j.1365-3083.2008.02205.x.
3.1.
2009
Hansen, M.; Eriste, E. Langel Ü. (2009). The Internalization mechanisms and Bioactivity of the Cell-Penetrating Peptides. In: Gröner, B. (Ed.). Peptides as Drugs: Discovery and Development, (125−143).. John Wiley & Sons Ltd.
1.1.
2005
Chen, J.; Kuei, C.; Sutton, S.W.; Bonaventure, P.; Nepomuceno, D.; Eriste, E.; Sillard, R.;Lovenberg, T.W.; Liu, C. (2005). Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species. Journal of Pharmacology and Experimental Therapeutics, 312 (1), 83−95.
1.1.
2005
Liu, C.; Kuei, C.; Sutton, S.; Chen, J.; Bonaventure, P.; Wu, J.; Nepomuceno, D.; Kamme, F.; Tran, D.T.; Zhu, J.; Wilkinson, T.; Bathgate, R.; Eriste, E.; Sillard, R.; Lovenberg, T.W. (2005). INSL5 is a high affinity specific agonist for GPCR142 (GPR 100). Journal of Biological Chemistry, 280 (1), 292−300.
1.1.
2005
Eriste, E.; Norberg, A.; Nepomuceno, D.; Kuei, C.; Kamme, F.; Tran, D.T.; Strumpat, K.; Jornvall, H.; Liu, C.; Lovenberg, T.W.; Sillard, R. (2005). A novel form of neurotensin post-translationally modified by arginylation. Journal of Biological Chemistry, 280 (42), 35089−35097.
1.1.
2003
Liu, C.; Eriste, E.; Sutton, S.; Chen, J.; Roland, B.; Kuei, C.; Farmer, N.; Jornvall, H.; Sillard, R.; Lovenberg, T.W. (2003). Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. Journal of Biological Chemistry, 278 (50), 50754−50764.
1.1.
2003
Palumaa, P.; Eriste, E.; Kruusel, K.; Kangur, L.; Jornvall, H.; Sillard, R (2003). Metal binding to brain-specific metallotifhonein-3 studied by electrospray ionization mass spectrometry. Cellular and Molecular Biology, 49 (5), 763−768.
1.1.
2003
Eriste, E.; Kruusel, K.; Palumaa, P.; Jornvall, H.; Sillard, R (2003). Purification of recombinant human apometallothionein-3 and reconstitution with zinc. Protein Expression and Purification, 31 (1), 161−165.
1.1.
2002
Palumaa, P.; Njunkova, O.; Pokras, L.; Eriste, E.; Sillard, R. (2002). Evidence for non-isostructural replacement of Zn<2+> with Cd<2+> in the beta-domain of brain-specific metallothionein-3. FEBS Letters, 527, 76−80.
1.1.
2002
Palumaa, P.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Sillard, R. (2002). Brain-specific metallothionein-3 has higher metal-binding capacity than ubiquitous metallothioneins and binds metals noncooperatively. Biochemistry, 41 (19), 6158−6163.
5.2.
2002
Palumaa, P.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Sillard, R. (2002). ESI TOF MS in protein structure analysis. MBB Meeting. Abstracts. Buffalo,.
5.2.
2002
"Palumaa, Peep;Eriste, Elo;Njunkova, Olga;Pokras, Lesja;Jörnvall, H.;Sillard, Rannar" (2002). Comparison of confirmations of zinc- and cadmium-substituted metallothionein-3 by ESI MS. The 50th ASMS Conference on Mass Spectrometry and Allied Topics. Orlando, puudub−puudub.
1.1.
2001
Chen, Z.; Eriste, E.; Jonsson, A. P.; Norberg, A.; Nepomuceno, D.; Lovenberg, T.W.; Bergman, T.; Efendic, S.; Jormvall, H.; Sillard, R. (2001). Ser(13)-phosphorylated PYY from porcine intestine with a potent biological activity. FEBS Letters, 492, 119−122.
1.1.
2001
Bonetto, V.; Eriste, E; Jonsson, A.P.; Efendic, S.; Jornvall, H.; Sillard, R. (2001). Isolation of peptides from porcine intestinal tissue that induce extracellular acidification in CHO cells : identification of the active peptide as IGF-I and characterization of a fragment of calponin H1 processed at a dibasic site. Archives of Biochemistry and Biophysics, 358 (2), 276−282.
5.2.
2001
Sillard, R.; Eriste, E.; Njunkova, O.; Pokras, L.; Jörnvall, H.; Wadensten, H.; Renlund, S.; Palumaa, P. (2001). Determination of metal-protein complexes and posttranslational modifications by LC-(ESI-TOF)-MS. Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics : Chicago, Illinois, May 27-31, 2001. 11−12.
1.1.
1999
Eriste, E.; Norberg, A.; Bonetto, V.; Nepomuceno, D.; Lowenberg, T.W., Sillard, R.; Jornvall, H. (1999). A C-terminally elongated form of PHI from porcine intestine. Cellular and Molecular Life Sciences, 56, 709−713.
1.1.
1999
Bonetto, V.; Eriste, E.; Metsis, M.; Sillard, R. (1999). Extracellular acidification: A novel detection system for ligand/receptor interactions. Demonstration with bioactive peptides and CHO or pancreatic beta cells, but of possible interest for tracing putative receptors in ethanol metabolism. Advances in Experimental Medicine and Biology, 463, 351−358.
1.1.
1998
Bonetto, V.; Eriste, E.; Sillard, R. (1998). Combination of fast chromatographic separations, biosensor-based functional assays, and mass spectrometry for characterization of complex peptide mixtures. Journal of Protein Chemistry, 17 (6), 555−556.
1.1.
1998
Kalda, A.; Eriste, E.; Vassiljev, V.; Zharkovsky, A. (1998). Medium transitory oxygen-glucose deprivation induced both apoptosis and necrosis in cerebellar granule cells. Neuroscience Letters, 240 (1), 21−24.
6.7.
1998
Eriste, Elo (1998). Ketamiini isomeeride neuroprotektiivse toime uurimine kahjustatud tserebellaarsete granulaarsete rakkude primaarkultuuris. (Magistritöö, Tartu Ülikool, Füüsika-keemiateaduskond). Tartu: Tartu Ülikool.
6.7.
1998
Eriste, E. (1998). Ketamiini isomeeride neuroprotektiivse toime uurimine kahjustatud tserebellaarsete granulaarsete rakkude primaarkultuuris. (Magistritöö). Tartu,: Tartu Ülikool, Orgaanilise ja bioorgaanilise keemia instituut.

Industrial property

20.11.2020

Otsi projekti

  • {{item.Name}}
Asutus on projekti finantseerija   Asutus on projekti teostaja  
  • {{searchListItem.Name}}
Kõik   Tavaprojektid   Ülemprojektid   Alamprojektid  
Uus Frascati (2015)
Uus ja vana Frascati (otsing uue järgi väljastab ka seotud vanad)
Kõik
Käimasolevad
Lõppenud
Algus
Hajus
Täpne
Lihtotsing Tühjenda
  • Leitud 6 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
MUUEU48695CCHT01.09.201531.08.2022Andres SalumetsTervisetehnoloogiate Arenduskeskus AS (endine Reproduktiivmeditsiini TAK AS) 6 916 472,93 EUR
SFSF0180027s08Koespetsiifilised transportvektorid01.01.200831.12.2013Ülo LangelTartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut600 272,61 EUR
ETFETF7494Metaboloomika põhine peptiidsete ravimikandidaatide ohutuse ja toimemehhanismide uurimine.01.01.200831.12.2011Kalle KilkTartu Ülikool, Arstiteaduskond59 514,48 EUR
MUUSLOTI12108T (32.1001.11-0008)PEPTIDE-BASED VECTORS FOR TUMOUR-TARGETED DELIVERY01.04.201231.08.2015Kaido KurrikoffTartu Ülikool524 506,50 EUR
IUTIUT20-26Trans-barrier targeting01.01.201431.12.2019Ülo LangelTartu Ülikool, Loodus- ja täppisteaduste valdkond, tehnoloogiainstituut889 200,00 EUR
ETFETF9438Uued meetodid therapeutikumide raku spetsiifiliseks sisestamiseks01.01.201201.12.2015Julia UusnaTartu Ülikool, Loodus- ja tehnoloogiateaduskond, Tartu Ülikooli Tehnoloogiainstituut46 440,00 EUR